Word of the day is ‘kuchisabishii’, from Japanese: boredom eating, or the making of frequent visits to the fridge in the hope of finding something new to munch on. Its literal translation is ‘lonely mouth’.

New publication 📝 Results from a retrospective analysis published in Bone Marrow Transplantation provide new insights for #myelofibrosis, see: loom.ly/QKuBhCY #MPN #MPNsm #GvHD

September is Blood Cancer Awareness Month. Connect the dots… #BloodCancerAwareness

We want you to be part of the conversation in TWO weeks! If you or someone you know has been diagnosed with blood cancer, we want help you connect with others who understand your journey, share experiences, and gain valuable insights by joining an empowering online webinar on

Pegasys (interferon) shortage - temporary due to manufacturing switch. Speak to your doctor if concerned. We'll keep you updated. More here - mpnvoice.org.uk/news/interfero… #mpnsm

CONGRESS | POSTER | #SOHO2024 | Prithviraj Bose Prithviraj Bose presents 3-year follow-up data from the phase III PATHFINDER study of avapritinib in pts with advanced systemic #mastocytosis (N=107). The ORR was 73% overall and 87% in treatment-naïve pts, with deep and sustained

CONGRESS | #SOHO2024 Laura C. Michaelis Medical College of Wisconsin discusses the goals of therapy in #EssentialThrombocythemia and PolycythemiaVera. Goals for both include managing venous and arterial thrombosis risk by correcting CV risk, providing appropriate anticoagulation, and

New publication 📝 Results from a retrospective analysis published in AmericanJournalofHematology provide new insights for #EssentialThrombocythemia, see: loom.ly/l8deaS0

#weekend_review #AML #leusm Continuing AML series from 8/31/24 1/ Overview of salvage therapies for relapse refractory AML #hemonctrainees #MedTwitter #hemoncfellows

Calling all Trainees - #BSH are looking for trainees to join our Guideline Task Forces Full details here: b-s-h.org.uk/about-us/volun… Closing date 30 September

Shout out for the KCH germline testing pathway at today’s #AMLAcademy Austin Kulasekararaj myeloidBMTteamkings

Tranfusion reaction algorithm

Are you a haematology trainee interested in pursuing a PhD? If so, this is a great opportunity to join our lab for an exciting project on the immune biology of Myeloproliferative Neoplasms. #MPN #PhD #clinical

This report is yet another glaring warning sign that the SEND system is failing children and needs urgent reform. It’s extremely worrying, and a scandal, that hundreds of children with SEND are missing from education. All children with SEND, including autistic children, should be

Coagulation cascade, fuck yeah🩸

Interference of Various Anticoagulants in Thrombophilia Testing 👇👇Very Good helpful chart Will make you appear as one sharp Haemostasis Cookie 😀 #medtwitter #meded #hematology #blooducation

New publication 📝 Results from a registry-based analysis published in Blood Advances provide new insights for #myelofibrosis, see: loom.ly/0rT6pj8

Beautiful data, elegantly presented by AK Eisfeld on AML genetics in Black pts at #iWAL24 PHIP mutations appear to be near exclusive in Black pts… Lookout for her tour de force paper out in Nature Genetics next week 🔥

Be part of the conversation TOMORROW! If you or someone you know has been diagnosed with blood cancer, we want to help you connect with others who understand your journey, share experiences, and gain valuable insights by joining an empowering online webinar on Wednesday 18th

Patients with hereditary hemorrhagic telangiectasia (HHT) received pomalidomide or placebo for 24 weeks. Pomalidomide reduced epistaxis frequency and severity. Full PATH-HHT trial results: nej.md/3MUk9VW